Investor Presentaiton
|||
Operations
and performance
Lucro Líquido e Lucro Líquido Ajustado
Net income for the period was R$ 395.2 million, while adjusted net
income was R$ 307.8 million. Net income was adjusted by the same
non-recurring expenses used to adjust EBITDA, net IR and CSLL, at the
rate of 34%, by tax indebtedness and others.
In 2021, the adjusted net margin was 5.1%, 2.1 p.p. up from 2020.
Proforma Results
As mentioned, throughout 2020 and 2021, several acquisitions were made by the company.
The Proforma figures for 2020 consider that all acquisitions made throughout 2020 are now
consolidated as of 1 January 2020. With the acquisition of Expressa, a drug distributor, Profor-
ma gross margin and EBITDA margin are lower than accounting margins, since the company
has a margin profile below Viveo's portfolio margin.
Economic-financial
results
AL
LO
MARI
R$ thousand
Distribution center - Brasilia (DF)
2020
2021
VIDAD GIL
2982
292482
Reported
Proforma
Reported
Proforma
Net Revenue
4,413,421
5,124,268
6,218,759
6,663,476
Adjusted Net Revenue
4,413,421
5,124,268
5,997,425
6,442,142
DHL
29
Adjusted Gross Profit
638,471
714,809
875,973
998,476
Adjusted Gross Margin
14.5%
Adjusted EBITDA
Gewrico
Adjusted Ebitda Margin
327,556
7.4%
13.9%
358,758
7.0%
14.6%
471,365
7.9%
15.5%
535,220
8.3%
viveo
45
The proforma figures for 2021 consider that the eight acquisitions completed over the year
began to be consolidated as of 1 January 2021. As the acquisitions were from the consumer
channels, laboratories, distribution of medical products, and services and have margins above
the average of Viveo's portfolio, the proforma gross margins and EBITDA are higher than
the accounting results. It should be noted that with the exception of the Daviso company.
all acquisitions were made in the fourth quarter of 2021 and gains from synergies should be
reaped in 2022 onward.
Sustainability Report 2021View entire presentation